Eam Investors, LLC Ocular Therapeutix, Inc Transaction History

Eam Investors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jul 12, 2023	BUY	$2.79 - $6.27 $217,438 - $488,652	77,935 Added 53.28%	224,211 $1.18 Million
Q1 2023 May 12, 2023	BUY	$2.79 - $6.27 $408,110 - $917,150	146,276 New	146,276 $770,000
Q1 2021 May 11, 2021	SELL	$15.82 - $22.11 $4.63 Million - $6.47 Million	-292,722 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$7.91 - $22.95 $287,330 - $833,658	36,325 Added 14.17%	292,722 $6.06 Million
Q3 2020 Nov 13, 2020	SELL	$7.36 - $9.87 $660,030 - $885,121	-89,678 Reduced 25.91%	256,397 $1.95 Million
Q1 2020 May 13, 2020	BUY	$3.95 - $7.4 $1.37 Million - $2.56 Million	346,075 New	346,075 $1.71 Million

151

136M

86.4K

263K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $668M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.